Can advances in brain scans and other testing techniques help us predict who will come down with Alzheimer’s — decades before symptoms show? Reisa Sperling of Brigham and Women’s Hospital reports on the latest research in battling a disease whose symptoms show up far too late to cure.
Reisa Sperling at TEDMED 2012
Sperling’s work in the Dominantly Inherited Alzheimer’s Network (DIAN) study was published July 11th in the New England Journal of Medicine. In this work, a team of researchers offered a timeline of the disease progression, with biomarkers, including changes in brain size and spinal fluid, evident as early as 25 years before the onset of symptoms. Read more about it here.
Our latest additions to the 2012 speaker lineup will offer a truly panoramic view of health and medicine today and far, far into the future. Through these amazing folks, we’ll have a peek at the wonders of human biology; understand the intricacies of surgery, robotics and neuroprosthetics; hear about novel, visionary tactics aimed at conquering public health challenges like aging, cancer, and tobacco use; and assess the very way we go about knowledge-sharing in the U.S.